Nhau dzinonakidza dzakabuda munguva pfupi yapfuura kubva kuCenter for Drug Evaluation (CDE) yeNational Medical Products Administration yeChina: kuyedzwa kwekiriniki kweKSD-101 Injection, yakagadzirwa neHensen Bio, kwabvumidzwa. Kushandiswa kwakaratidzwa ndekwe "EBV-associated hematological bundu dzisina kupindura kurapwa kwakajairika."
Kurapa uku kuri kuitwa kuti kushandiswe nevarwere vanokodzera pasi rese kuburikidza ne **Beijing South Region Oncology Hospital International Department**. Takazvipira kushandura tsvakurudzo yesainzi yemazuva ano kuita mabasa ekurapa, tichipa varwere vekune dzimwe nyika mabasa ekurapa epamusoro uye sarudzo itsva yekurapa.
KSD-101 mushonga wekudzivirira masero emuviri, unobva mumasero evanhu uye une maantigen anokonzerwa neEBV. Zvakawanikwa kubva mukuyedzwa kwayo kwekiriniki kwePhase I zvakaratidzwa paMusangano weGore Negore we2025 weEuropean Hematology Association (EHA), zvichiratidza kugona kwayo kukuru mukurapa immune therapy.
Chidzidzo chekiriniki chePhase I chakanyoresa varwere vane marudzi akasiyana-siyana ezvirwere zveEpstein-Barr virus-associated lymphoproliferative (EBV-LPDs), kusanganisira mamiriro akasiyana-siyana ekusagadzikana akadai seAngioimmunoblastic T-cell Lymphoma (AITL), Nasal-type/Peripheral NK/T-cell Lymphoma (ENKTL), Chronic Active Epstein-Barr Virus infection (CAEBV), EBV-associated Hemophagocytic Lymphohistiocytosis (HLH), Diffuse Large B-cell Lymphoma (DLBCL), uye Hodgkin Lymphoma (HL).
Zvakabuda muongororo zvakaratidza kuti pakutevera kwemavhiki makumi mana nemaviri nemazana manomwe (42.7), kurapwa neKSD-101 kwakaita kuti chirwere chisaparare, uye ruzhinji rwevarwere rwakawana uye rwakaramba ruchiregererwa zvizere (CR). Ruzivo urwu runopa tariro itsva kuvarwere vakakundikana kurapwa kwakajairika.
Panyaya yekuchengetedzeka, zviitiko zvisina kunaka zvine chekuita nekurapwa (AEs) zvaive zvakanyanya kuita zvisina kusimba, zvakaita sekuita panzvimbo yekubaiwa jekiseni, fivha, uye lymphadenopathy. Hapana chepfu yeGiredhi ≥3 yakaonekwa, zvichiratidza kuti inogona kushivirira. Izvi zvinoratidza kuti KSD-101 haingori chete inoshanda asiwo yakachengeteka, ichitsigira kugona kwayo kurapwa kwenguva refu.
**Sei Uchifanira Kusarudza Dhipatimendi Repasirose reBeijing South Region Oncology Hospital?**
Senzvimbo yekurapa inovimbwa nayo yevarwere vekune dzimwe nyika, tinopa mabasa ekurapa epasi rose akazara uye ane mitauro yakawanda. Kubva pakuongororwa kwekutanga uye kugadzirisa hurongwa hwekurapa kusvika pakuteverwa kunotevera, timu yedu yenyanzvi yakazvipira kupa rubatsiro rwekurapa rwakagadzirirwa murwere wese wekune dzimwe nyika.
Musarega miganhu yenzvimbo ichikuganhurirai kuwana kurapwa kwakanakisisa. Kana imi kana nhengo yemhuri yenyu muchirwara neEBV-associated hematological bundu uye musina kupindura kurapwa kwakajairika, ndapota taurai nesu nekukasika.
**Tibatei Iye Zvino Kuti Muone Chirongwa Chekurapwa**
Chikwata chedu cheDhipatimendi Renyika Dzepasi Pose chakagadzirira kukubatsira. Munogona kutibata kuburikidza neimwe yenzira dzinotevera kuti mutange rwendo rwenyu rwekurapwa kwepamusoro:
- ��� Kubvunzana nefoni: 400-880-3716
- ��� Kubvunzana paWeChat: 17801183037
- ��� Email:
- 100085_010@163.com
- myimmnet@163.com
**Dhipatimendi rePasirose reChipatara cheOncology cheBeijing South Region**
Hwindo Renyu Renyika Dzese Rekurapwa Kwegomarara
Nguva yekutumira: Kurume-12-2026